GlassScriptPhysician profile
Thomas G Prater
NPI 1043289119
$30,395.88
in general payments reported to CMS, 2019-2025
14 companies · $2,096 in 2025
The $2,096 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $137 · 2021: $258 · 2022: $7,347 · 2023: $20K · 2024: $107 · 2025: $2,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $21K · Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $21,425.24 |
| Food and Beverage | $877.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $28,721.29 | 2022-2025 | Ellipsys Vascular Access System |
| Alcon Vision LLC | $476.41 | 2019-2025 | Acrysof Iq Panoptix Uv Iol, Clareon, Rocklatan |
| Ocular Therapeutix, INC. | $289.75 | 2023 | Dextenza |
| Sun Pharmaceutical Industries INC. | $230.30 | 2019-2021 | |
| Rxsight INC | $227.17 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Aerie Pharmaceuticals, INC. | $103.30 | 2019 | |
| Bausch Health US, LLC | $102.44 | 2020 | |
| Allergan, INC. | $84.71 | 2021 | |
| Abbvie INC. | $49.18 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $34.67 | 2020 | |
| Oyster Point Pharma, INC. | $23.68 | 2023 | Tyrvaya |
| Genentech USA, INC. | $22.65 | 2025 | Vabysmo |
| Bausch & Lomb Americas INC. | $15.44 | 2024 | Miebo |
| Harrow Eye, LLC | $14.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Prater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.